294 results
Categories
Human Remove Human filter
-
List item
Withdrawn application: Feraheme
ferumoxytol, date of withdrawal: 09/03/2023, Initial authorisation, Last updated: 31/03/2023Feraheme: Withdrawn application … ferumoxytol Overview Covis Pharma Europe B.V … Europe B.V. withdrew its application for a The approval to market … -
List item
Withdrawn application: Orepaxam
treprostinil diolamine, date of withdrawal: 11/10/2022, Initial authorisation, Last updated: 11/11/2022Orepaxam: Withdrawn application … Internacional S.A. withdrew its application for a The approval to market … The company withdrew the application on 11 October 2022. Expand … -
List item
Withdrawn application: Pioglitazone ratio
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratio: Withdrawn application … pioglitazone Overview On 3 February 2012, ratiopharm … it wishes to withdraw its application for a marketing authorisation … -
List item
Withdrawn application: Pioglitazone ratiopharm
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm: Withdrawn application … pioglitazone Overview On 3 February 2012, ratiopharm … it wishes to withdraw its application for a marketing authorisation … -
List item
Withdrawn application: Repaglinide Sun
repaglinide, date of withdrawal: 25/03/2010, Initial authorisation, Last updated: 15/05/2010Repaglinide Sun: Withdrawn application … repaglinide Overview On 23 March 2010, Sun Pharmaceutical … it wished to withdraw its application for a marketing authorisation … -
List item
Withdrawn application: Docetaxel Mylan
docetaxel, date of withdrawal: 08/03/2010, Initial authorisation, Last updated: 26/03/2010Docetaxel Mylan: Withdrawn application … docetaxel Overview On 8 March 2010, Mylan S.A.S … it wishes to withdraw its application for a marketing authorisation … -
List item
Withdrawn application: Buvidal
buprenorphine, date of withdrawal: 13/02/2023, Post-authorisation, Last updated: 24/02/2023Buvidal: Withdrawn application … buprenorphine Overview Camurus AB withdrew its application for the use of Buvidal to … The company withdrew the application on 13 February 2023. What … -
List item
Withdrawn application: Restaysis
ciclosporin, date of withdrawal: 25/04/2018, Initial authorisation, Last updated: 06/08/2018Restaysis: Withdrawn application … ciclosporin Overview On 25 April 2018, Allergan … it wished to withdraw its application for a The approval to market … -
List item
Withdrawn application: Rotigotine Mylan
rotigotine, date of withdrawal: 22/12/2017, Initial authorisation, Last updated: 11/07/2018Rotigotine Mylan: Withdrawn application … rotigotine Overview On 22 December 2017, Mylan … it wishes to withdraw its application for a The approval to market … -
List item
Withdrawn application: Tigecycline Accord
tigecycline, date of withdrawal: 12/09/2017, Initial authorisation, Last updated: 10/10/2017Tigecycline Accord: Withdrawn application … tigecycline Overview On 12 September 2017, Accord … it wishes to withdraw its application for a The approval to market … -
List item
Withdrawn application: Ertapenem Hospira
ertapenem, date of withdrawal: 13/09/2016, Initial authorisation, Last updated: 06/12/2016Ertapenem Hospira: Withdrawn application … ertapenem Overview On 13 September 2016, Hospira … it wishes to withdraw its application for a The approval to market … -
List item
Withdrawn application: Duloxetine Sandoz
duloxetine, date of withdrawal: 08/04/2015, Initial authorisation, Last updated: 24/04/2015Duloxetine Sandoz: Withdrawn application … duloxetine Overview On 08 April 2015, Sandoz … it wishes to withdraw its application for a The approval to market … -
List item
Withdrawn application: Aripiprazole Mylan
aripiprazole, date of withdrawal: 07/05/2015, Initial authorisation, Last updated: 20/07/2015Aripiprazole Mylan: Withdrawn application … aripiprazole Overview On 7 May 2015, Generics (UK … it wishes to withdraw its application for a The approval to market … -
List item
Withdrawn application: Parsaclisib Incyte Biosciences Distribution B.V.
parsaclisib, date of withdrawal: 27/06/2022, Initial authorisation, Last updated: 08/11/2022Biosciences Distribution B.V.: Withdrawn application … parsaclisib Overview Incyte Biosciences Distribution … Distribution B.V. withdrew the application for a The approval to market … -
List item
Withdrawn application: Ibandronic Acid Hexal
ibandronic acid, date of withdrawal: 21/07/2011, Initial authorisation, Last updated: 22/08/2011Ibandronic Acid Hexal: Withdrawn application … ibandronic acid Overview On 21 July 2011, Hexal AG … it wishes to withdraw its application for a marketing authorisation … -
List item
Withdrawn application: Pioglitazone Teva Generics
pioglitazone, date of withdrawal: 26/01/2012, Initial authorisation, Last updated: 03/07/2012Pioglitazone Teva Generics: Withdrawn application … pioglitazone Overview On 26 January 2012, Teva … it wishes to withdraw its application for a marketing authorisation … -
List item
Withdrawn application: Pioglitazone ratiopharm GmbH
pioglitazone, date of withdrawal: 03/02/2012, Initial authorisation, Last updated: 30/04/2012Pioglitazone ratiopharm GmbH: Withdrawn application … pioglitazone Overview On 3 February 2012, ratiopharm … it wishes to withdraw its application for a marketing authorisation … -
List item
Withdrawn application: Clopidogrel Teva Pharma
clopidogrel, date of withdrawal: 22/04/2009, Initial authorisation, Last updated: 23/04/2009Clopidogrel Teva Pharma: Withdrawn application … clopidogrel Overview On 22 April 2009, Teva Pharma … it wished to withdraw its application for a marketing authorisation … -
List item
Withdrawn application: Olumiant
baricitinib, date of withdrawal: 07/12/2022, Post-authorisation, Last updated: 02/02/2023Olumiant: Withdrawn application … EMEA/H/C/004085/II/0028 Withdrawal of application to change the marketing authorisation … Nederland B.V. withdrew its application for the use of Olumiant in … -
List item
Withdrawn application: Doxorubicin Hydrochloride Tillomed
doxorubicin, date of withdrawal: 02/03/2020, Initial authorisation, Last updated: 27/07/2020icin Hydrochloride Tillomed: Withdrawn application … doxorubicin Overview Laboratorios Tillomed Spain … Spain S.L.U. withdrew its application for a The approval to market … -
List item
Withdrawn application: Imcivree
setmelanotide, date of withdrawal: 22/04/2022, Post-authorisation, Last updated: 28/09/2022Imcivree: Withdrawn application … EMEA/H/C/005089/II/0002/G Withdrawal of application to change the marketing authorisation … Netherlands B.V. withdrew its application for the use of Imcivree to … -
List item
Withdrawn application: Brilique
ticagrelor, date of withdrawal: 15/12/2021, Post-authorisation, Last updated: 01/04/2022Brilique: Withdrawn application … EMEA/H/C/001241/II/0049 Withdrawal of application to change the marketing authorisation … AstraZeneca AB withdrew its application for the use of Brilique in … -
List item
Withdrawn application: Cervarix
human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), date of withdrawal: 22/10/2021, Post-authorisation, Last updated: 10/01/2022Cervarix: Withdrawn application … EMEA/H/C/000721/II/0110 Withdrawal of application to change the marketing authorisation … Biologicals SA withdrew its application to use Cervarix in individuals … -
List item
Withdrawn application: Livmarli
maralixibat, date of withdrawal: 23/08/2021, Initial authorisation, Last updated: 17/12/2021Livmarli: Withdrawn application … EMEA/H/C/005551 Withdrawal of application for the marketing authorisation … Service GmbH withdrew its application for a marketing authorisation … -
List item
Withdrawn application: Sildenafil FGK
sildenafil, date of withdrawal: 19/07/2021, Initial authorisation, Last updated: 05/10/2021Sildenafil FGK: Withdrawn application … EMEA/H/C/005439 Withdrawal of application for the marketing authorisation … Service GmbH withdrew its application for a marketing authorisation …